Short answer · Medically reviewed summary · Last updated: 2026-05-08
BPES (Blepharophimosis Ptosis Epicanthus Inversus Syndrome) is a rare genetic disorder with an estimated prevalence of approximately 1 in 50,000 to 1 in 100,000 individuals worldwide. Because Blepharophimosis Ptosis Epicanthus Inversus Syndrome is often underdiagnosed or misidentified as milder eyelid anomalies, these figures are considered estimates rather than exact counts. Is BPES considered a rare disease? Yes, Blepharophimosis Ptosis Epicanthus Inversus Syndrome is classified as a rare condition.
What is the prevalence of BPES - Blepharophimosis Ptosis Epicanthus Inversus Syndrome?
Prevalence of BPES - Blepharophimosis Ptosis Epicanthus Inversus Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
BPES (Blepharophimosis Ptosis Epicanthus Inversus Syndrome) is a rare genetic disorder with an estimated prevalence of approximately 1 in 50,000 to 1 in 100,000 individuals worldwide. Because Blepharophimosis Ptosis Epicanthus Inversus Syndrome is often underdiagnosed or misidentified as milder eyelid anomalies, these figures are considered estimates rather than exact counts.
Is BPES considered a rare disease?
Yes, Blepharophimosis Ptosis Epicanthus Inversus Syndrome is classified as a rare condition. While the exact incidence is difficult to track, it is estimated that the prevalence of BPES is roughly 1 per 50,000–100,000 people. Many cases may go unreported in clinical literature, particularly in regions with limited access to specialized genetic counseling or ophthalmic plastic surgery.
How does BPES affect different populations?
Blepharophimosis Ptosis Epicanthus Inversus Syndrome affects males and females equally, as the causative gene (FOXL2) is located on chromosome 3. The condition is congenital, meaning it is present at birth, and it does not show significant geographic or ethnic variation in prevalence. However, the phenotypic expression of BPES can vary significantly even within the same family, which often complicates epidemiological data collection.
Why is accurate data for BPES difficult to obtain?
Several factors contribute to the challenge of determining the true prevalence of Blepharophimosis Ptosis Epicanthus Inversus Syndrome:
- Underdiagnosis: Milder presentations of BPES may be overlooked by primary care providers.
- Misdiagnosis: The physical features are sometimes attributed to unrelated congenital eyelid conditions.
- Variable Expressivity: The symptoms of BPES range from mild to severe, leading to inconsistent reporting in medical databases.
- Community Insight: At DiseaseMaps.org, we currently support 70 individuals with BPES, providing a vital real-world perspective that complements clinical statistics and highlights the lived experience of the community.
Next steps
- Consult with a clinical geneticist to confirm a diagnosis through FOXL2 mutation testing.
- Schedule an evaluation with an oculoplastic surgeon experienced in managing the complex eyelid anatomy associated with BPES.
- Connect with the 70 members at DiseaseMaps.org to share experiences and learn about ongoing research.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- Orphanet: Blepharophimosis-ptosis-epicanthus inversus syndrome (ORPHA:126).
- NIH Genetic and Rare Diseases Information Center (GARD): Blepharophimosis, ptosis, and epicanthus inversus syndrome.
- OMIM (Online Mendelian Inheritance in Man): #110100 (BPES Type I) and #110100 (BPES Type II).
